Cite
Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality: A Systematic Review and Meta-analysis.
MLA
Baboudjian, Michael, et al. “Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality: A Systematic Review and Meta-Analysis.” JAMA Oncology, vol. 9, no. 6, June 2023, pp. 847–50. EBSCOhost, https://doi.org/10.1001/jamaoncol.2023.0260.
APA
Baboudjian, M., Gondran-Tellier, B., Dariane, C., Fiard, G., Fromont, G., Rouprêt, M., & Ploussard, G. (2023). Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality: A Systematic Review and Meta-analysis. JAMA Oncology, 9(6), 847–850. https://doi.org/10.1001/jamaoncol.2023.0260
Chicago
Baboudjian, Michael, Bastien Gondran-Tellier, Charles Dariane, Gaëlle Fiard, Gaëlle Fromont, Morgan Rouprêt, and Guillaume Ploussard. 2023. “Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality: A Systematic Review and Meta-Analysis.” JAMA Oncology 9 (6): 847–50. doi:10.1001/jamaoncol.2023.0260.